Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOST-EXAM: Clopidogrel vs. Aspirin Monotherapy After DES Implantation
NCT02044250Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2014
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary heart disease (CHD), sponsored by Seoul National University Hospital. Started Feb 2014; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT02044250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044250.